Ketan Patel

Ketan Patel is an Indian pharmacist, innovator, and serves as the chairman & managing director of Troikaa Pharmaceuticals, a pharmaceutical company headquartered in Gujarat, India.

Uses your system voice; voice and rate in settings.

≈ 2 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Ketan Patel is an Indian pharmacist, innovator, and serves as the chairman & managing director of Troikaa Pharmaceuticals, a pharmaceutical company headquartered in Gujarat, India. Patel is the chairman of the Board of Governors at National Institute of Pharmaceutical Education & Research (NIPER), Gandhinagar.

Education & career

Patel earned Gold Medals during both his Bachelor of Pharmacy and Master of Pharmacy programs from L. M. College of Pharmacy, Ahmedabad. He received a Ph.D. in Pharmaceutical Technology, which he obtained from Dharamsinh Desai University, Gujarat. Patel established the "Rajnibhai.V.

Patel Pharmlnnova Award" under the aegis of the Department of Science and Technology (India). Details of his career are documented in the book titled 'THE INNOVATORS,' published by the Department of Science and Technology (India) Government of India.

Invention

Patel is the primary inventor and patent holder of a painless diclofenac injection marketed under the brand name 'DYNAPAR-AQ' by Troikaa Pharmaceuticals Ltd. His innovation earned recognition from the Government of India’s Department of Science & Industrial Research, which honored him with the National Award in 2008. In 2008, he invented a quick, powerful & long-lasting penetrating solution of Diclofenac designed for Topical administration known as “Dynapar QPS”, for which he was conferred with a National Award in 2015 from the Department of Science & Technology, Govt of India.

In 2019, he introduced a solution for Vitamin B12 deficiency. NasoB12, the world's first globally approved nasal drug delivery system, utilizes Methylcobalamin, the biologically active form of Vitamin B12, to effectively address Vitamin B12 deficiency, which has high prevalence in India and developing nations.

NASO B12 was honored with the "India Star Award" for outstanding packaging design. This award was provided by the Indian Institute of Packaging, an autonomous body operating under the aegis of the Ministry of Commerce and Industry, Government of India. In 2023, Xykaa IM, world’s first 500 mg Paracetamol/2ml injection was introduced by Ketan Patel and Milan Patel.

Awards and honors

in 2011 National Award by Department of Scientific & Industrial Research (DSIR) in 2011, facilitated by former President of India – A.P.J. Abdul Kalam for R&D efforts

Text derived from https://en.wikipedia.org/w/index.php?oldid=1372555418 under CC BY-SA 4.0; modifications have been made.

Words in each sectionInventionInventionInvention: 198 words198Education & careerEducation & careerEducation & career: 85 words85Awards and honorsAwards and honorsAwards and honors: 51 words51
Words in each section. Measured from the stored article body; sections below the minimum are not plotted.

Provenance

snapshot enwiki-001372555418 · captured 2026-09-01 · ledger · version history

Cite this page as: encyclopegia.org, “Ketan Patel”, snapshot enwiki-001372555418. https://encyclopegia.org/a/ketan-patel

Sources cited in this revision

12 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.